Alpha Phi Alpha Fraternity | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,680 results for “Alpha Phi Alpha Fraternity”

Takeda Achieves Diversity Milestone in Phase 3 Psoriasis Trial with Zasocitinib

Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility

Alpha Tau Initiates First U.S. Patient Treatment in Pancreatic Cancer Trial Combining Alpha DaRT with Chemotherapy

FDA Approves Lamzede for Alpha-Mannosidosis Treatment

Alpha Tau Receives FDA TAP Acceptance to Expedite Alpha DaRT for Recurrent Glioblastoma

FDA Approves Alpha Tau's IDE for Alpha DaRT Study in Immunocompromised cSCC Patients

Alpha Tau Medical's Alpha DaRT Receives FDA Support and Advances in Clinical Trials

Alpha Tau's Alpha DaRT Therapy Receives FDA Nod for Expanded Pancreatic Cancer Trial

Alpha Tau Medical's Alpha DaRT Receives FDA Advisory Program Acceptance and Advances Clinical Trials

Alpha Cognition Announces Executive Changes and Receives Regulatory Approval

Page 1 of 101